Vedolizumab

Min.Order / FOB Price:Get Latest Price

0	Negotiable

Product Details
Company Profile

Min.Order :0
Purity: 95%

Keywords

Entyvio

Quick Details

Appearance:
Application:the treatment of ulcerative colitis and Crohn's disease
PackAge:
ProductionCapacity:
Storage:
Transportation:

Superiority:

We provide customized and high-quality Vedolizumab product for your project.

Details:

Vedolizumab is a monoclonal antibody developed by Millennium Pharmaceuticals for the treatment of ulcerative colitis and Crohn's disease under the trade name Entyvio. Vedolizumab binds to integrin α4β7 (LPAM-1) and blocks α4β7, displaying anti-inflammatory activity.

View All